Picture of InspireMD logo

NSPR InspireMD News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapNeutral

InspireMD Inc reports results for the quarter ended in September - Earnings Summary

* InspireMD Inc  NSPR.OQ  reported a quarterly adjusted loss
of 58
cents​​ per share for the quarter ended in September. The lone
analyst forecast for the quarter was for a loss of 73 cents per
share.
    * Revenue rose 33.6% to $1.43 million from a year ago;
analysts
expected $1.40 million. 
    * InspireMD Inc's reported EPS for the quarter was a loss
of 58
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * InspireMD Inc shares had fallen by 27.1% this quarter and
lost 64.2% so far this year.
    * The company reported a quarterly loss of $4.53 million.
    * Wall Street's median 12-month price target for InspireMD
Inc is
$5.60 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
8 at 02:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.73          -0.58          Beat
 Jun. 30 2022      -0.73          -0.59          Beat
 Mar. 31 2022      -0.80          -0.57          Beat
 Dec. 31 2021      -0.78          -0.53          Beat

Recent news on InspireMD

See all news